medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2011, Number 2

<< Back Next >>

Rev Biomed 2011; 22 (2)

Prevalence of the metabolic syndrome in adults living in Merida, Yucatan, Mexico

Castro-Sansores CJ, Hernández-Escalante V, Arjona-Villicaña R

Language: Spanish
References: 22
Page: 49-58
PDF size: 288.50 Kb.


ABSTRACT

Introduction. A significant number of the population in Mexico exhibit metabolic syndrome. For this reason, this program evaluates the prevalence of metabolic syndrome in a population of asymptomatic subjects and to determine its association with the different analyzed variables..
Materials and Methods. Of September 2008 to December of 2009, of pFrom September 2008 to December of 2009, prospective methods were evaluated for subjects between the 20 and 75 years of age, among patients being treated for reasons different from cardiometabolic diseases at the external Internal Medicine area of a second tier hospital. Previous informed consent, laboratory studies, and anthropometric measurements were taken, and a questionnaire designed for the study was completed.
Results. 204 total subjects were evaluated, as 138 women (68%) and 66 men (32%), with an age average of 58 years (24-75). One hundred subjects (49%) met the criteria for the metabolic syndrome. There were more women with metabolic syndrome (57% versus 33%, p=0.003).
The number of components of the metabolic syndrome had a direct correlation with the degree of nonalcoholic fatty liver, measured indirectly.
Conclusions. The prevalence of metabolic syndrome in Yucatan is similar to those previously reported at the national level. Metabolic syndrome was correlated with the degree of hepatic fat infiltration, determined indirectly


REFERENCES

  1. Martínez MA, Puig JG, Mora M, Aragón R, O’Dogherty P, Antón JL, et al.; MAPA (Monitorización Ambulatoria de la Presión Arterial) Working Group. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgoCardiovascular) Study. Metabolism 2008; 57:1232-40.

  2. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28:2289–2304.

  3. Aguilar-Salinas C, Rojas B, Gómez-Pérez FJ, Valles V, et al. Analysis of the agreement between World Health Organization criteria and the National Cholesterol Education program-III definition of the metabolic syndrome: results from a population-based study. Diabetes Care 2003; 26:1653.

  4. González-Ortiz M, Martínez-Abundis E, Jacques-Camarena O, Hernández-González SO, Valera-González IG, Ramos-Zavala MG. Prevalence of metabolic syndrome in adults with excess of adiposity: comparison of the Adult Treatment Panel III criteria with the International Diabetes Federation definition. Acta Diabetol. 2006 ;43:84-6.

  5. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar-Salinas C, Cravioto P, et al. Encuesta Nacional de Salud 2000. La salud de los adultos. Cuernavaca, Morelos: Instituto Nacional de Salud Pública, 2003.

  6. Pinzón JB, Serrano NC, Díaz LA, Mantilla G, Velasco HM, Martínez LX, et al. Impacto de las nuevas definiciones en la prevalencia del síndrome metabólico en una población adulta de Bucaramanga, Colombia. 2007;27:172-9.

  7. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 16: 356-59.

  8. Ramírez-Vargas E, Arnaud-Viñas MR, Delisle H. Prevalence of the metabolic syndrome and associated lifestyles in adult males from Oaxaca, Mexico. Salud Publica Mex 2007;49:94-102.

  9. González-Chávez A, Simental L, Elizondo-Argueta S, Sánchez-Zúñiga J, Gutiérrez-Salgado G, Gue-rrero-Romero F. Prevalencia del síndrome metabólico entre adultos mexicanos no diabéticos, usando las definiciones de la OMS, NCEP-ATPIIIa e IDF. Rev Med Hosp Gen Mex 2008; 71:11-19.

  10. Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome a new worldwide definition. Lancet 2005; 366:1059-62.

  11. Olaiz G, Rivera J, Shamah T, Rojas R, Villalpando S, Hernández M, et al. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, Morelos: Instituto Nacional de Salud Pública, 2006.

  12. Lee DH, Jacobs DR, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. γ-Glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003;49:1358–66.

  13. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology 2006, 6:33-9.

  14. Frohlich J, Dobiasova M. Fractional Esterification Rate of Cholesterol and Ratio of Triglycerides to HDL-Cholesterol Are Powerful Predictors of Positive Findings on Coronary Angiography. Clinical Chemistry 2003; 49: 1873–80.

  15. Escobedo J, Schargrodsky H, Champagne B, Silva H, Boissonnet CP, Vinueza R, et al. Prevalence of the Metabolic Syndrome in Latin America and its association with subclinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovascular Diabetology 2009, 8:52.

  16. Valenzuela AA, Maíz A, Margozzini P, Ferreccio C, Rigotti A, Olea R, et al. Prevalence of metabolic syndrome among Chilean adults. Rev Med Chil. 2010;138:707-14.

  17. Athyros VG, Ganotakis ES, Tziomalos K, Papageor giou AA, Anagnostis P, Griva T, et al. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Curr Med Res Opin. 2010;26:713-9.

  18. Pemminati S, Prabha Adhikari MR, Pathak R, Pai MR. Prevalence of metabolic syndrome (METS) using IDF 2005 guidelines in a semi urban south Indian (Boloor Diabetes Study) population of Mangalore. J Assoc Physicians India. 2010;58:674-7.

  19. Siminialayi IM, Emem-Chioma PC, Odia OJ. Prevalence of metabolic syndrome in urban and suburban Rivers State, Nigeria: International Diabetes Federation and Adult Treatment Panel III definitions. Niger Postgrad Med J. 2010;17:147-53.

  20. Hodis HN. Triglyceride-rich lipoproteins remnant particles and risk of atherosclerosis. Circulation 1999: 99: 2852-4.

  21. Bergman, R. N. et al. Why visceral fat is bad: mechanisms of the metabolic syndrome. Obesity (Silver Spring) 14 (Suppl. 1), 16S–19S (2006).

  22. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005, 42:44-52..




2020     |     www.medigraphic.com